Levofloxacin vs Nivolumab
Levofloxacin vs Nivolumab: Overview
This comparison examines the pharmacological differences between Levofloxacin and Nivolumab.
Mechanism of Action
Levofloxacin: Fluoroquinolone antibiotic inhibiting bacterial DNA gyrase and topoisomerase IV.
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Pharmacokinetics
Half-life: Levofloxacin — 6-8 hours; Nivolumab — 27 days.
Chemical Properties
Molecular Formula: Levofloxacin — C18H20FN3O4.
Molecular Weight: Levofloxacin — 361.3680 g/mol.
Type: Levofloxacin — Small molecule; Nivolumab — Antibody.